Prudential Financial
NVCR icon

Prudential Financial’s NovoCure NVCR Stock Holding History

Prudential Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
17,650
+2,220
+14% +$33.6K ﹤0.01% 2138
2026
Q1 		$168K Buy
+15,430
New +$193K ﹤0.01% 2168
2025
Q4 		– Sell
-12,155
Closed -$157K – 2366
2025
Q3 		$157K Buy
12,155
+35
+0.3% +$468 ﹤0.01% 2242
2025
Q2 		$216K Buy
+12,120
New +$211K ﹤0.01% 2185
2025
Q1 		– Sell
-7,170
Closed -$214K – 2353
2024
Q4 		$214K Buy
+7,170
New +$152K ﹤0.01% 2076
2022
Q1 		– Sell
-1,998
Closed -$214K – 2667
2021
Q4 		$214K Sell
1,998
-201
-9% -$20.2K ﹤0.01% 2526
2021
Q3 		$288K Sell
2,199
-49
-2% -$7.41K ﹤0.01% 2341
2021
Q2 		$498K Sell
2,248
-30
-1% -$5.84K ﹤0.01% 2140
2021
Q1 		$301K Hold
2,278
– – ﹤0.01% 2271
2020
Q4 		$395K Sell
2,278
-34
-1% -$4.65K ﹤0.01% 2158
2020
Q3 		$257K Buy
+2,312
New +$185K ﹤0.01% 2218
2020
Q2 		– Sell
-38,537
Closed -$2.6M – 2448
2020
Q1 		$2.6M Buy
38,537
+30,326
+369% +$2.4M 0.01% 1240
2019
Q4 		$692K Sell
8,211
-309
-4% -$24.9K ﹤0.01% 1974
2019
Q3 		$637K Sell
8,520
-66,743
-89% -$5.34M ﹤0.01% 1984
2019
Q2 		$4.76M Buy
75,263
+67,873
+918% +$3.44M 0.01% 1182
2019
Q1 		$356K Buy
+7,390
New +$356K ﹤0.01% 2175
2018
Q4 		– Sell
-7,430
Closed -$389K – 2427
2018
Q3 		$389K Buy
7,430
+840
+13% +$33.4K ﹤0.01% 2114
2018
Q2 		$206K Buy
+6,590
New +$183K ﹤0.01% 2338

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Prudential Financial's NVCR Position: Q2 2026 in Review

Prudential Financial increased its NovoCure (NVCR) stake by 14% in Q2 2026, buying an estimated $33.6K and bringing the position to 17,650 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Prudential Financial first reported a position in NVCR in Q2 2018 and has held it in 18 quarters since. The position peaked at $4.76M in Q2 2019. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Prudential Financial held 17,650 shares of NovoCure worth $267K as of Q2 2026.
  • Prudential Financial bought 2,220 NovoCure shares in Q2 2026, an estimated $33.6K.
  • NovoCure made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2138 holding.
  • Prudential Financial first reported a position in NovoCure in Q2 2018 and has held it in 18 quarters since.
  • Prudential Financial's NovoCure position peaked at $4.76M in Q2 2019.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.